How can goal directed therapy be used to prevent acute kidney injury (AKI)? What do we know about AKI? Which members of the surgical team should be involved in AKI detection? Where do we stand on ACE inhibitors (angiotensin converting enzyme inhibitors) and ARBs (angiotensin-receptor blockers)? Where should a perioperative practitioner stand on the choice between restrictive versus liberal fluid therapy?

The slides for this piece are here:

Presented by Vincent D’Intini, Senior staff specialist, Nephrologist, Alfred Hospital Melbourne.

Brought to you by the Perioperative Medicine Special Interest Group (SIG) in association with the Australian and New Zealand Society for Geriatric Medicine and the Internal Medicine Society of Australia and New Zealand at the 7th annual Australasian Symposium of Perioperative Medicine.

The Perioperative Medicine Special Interest Group (SIG) has three aims; improve patient safety and outcomes, share knowledge and collaborate with specialty groups, develop the specialty of perioperative medicine with various craft groups.

For more information follow this link here: